International Conference on Obesity-related Immune Dysregulation

This track will explore the underlying mechanisms linking obesity with immune dysregulation through the lens of immunometabolism. Presentations will focus on cellular and molecular pathways that contribute to metabolic inflammation in adipose tissue.

This session will examine the role of adipose tissue in modulating immune responses and its implications for metabolic health. Discussions will include the interplay between adipocytes and immune cells in the context of obesity-related inflammation.

This track will delve into the relationship between chronic inflammation and the development of metabolic syndrome. Researchers will present findings on how immune dysregulation contributes to the pathophysiology of metabolic disorders.

This session will focus on the metabolic alterations in immune cells associated with obesity. Presentations will highlight how these changes influence immune function and contribute to obesity-related diseases.

This track will investigate the bidirectional relationship between metabolic health and immune function. Researchers will discuss how improving metabolic health can potentially restore immune balance in obese individuals.

This session will explore the role of various inflammatory mediators in the context of obesity and immune dysregulation. Presentations will cover cytokines, chemokines, and other factors that drive metabolic inflammation.

This track will discuss novel therapeutic strategies aimed at addressing immunometabolic disorders linked to obesity. Researchers will present innovative approaches targeting immune pathways to improve metabolic outcomes.

This session will examine the influence of the gut microbiome on immune dysregulation and metabolic health in obesity. Presentations will highlight how microbial composition can affect inflammation and metabolic processes.

This track will focus on the role of adipokines in mediating interactions between adipose tissue and the immune system. Researchers will discuss how these signaling molecules influence inflammation and metabolic health.

This session will explore how obesity-related immune changes vary across different life stages. Presentations will highlight the implications of these changes for long-term metabolic health.

This track will showcase translational research efforts aimed at bridging the gap between basic immunometabolism and clinical applications. Researchers will present findings that could inform future therapeutic interventions for obesity-related immune dysregulation.